Literature DB >> 30743772

Antithyroid drug therapy of Graves' hyperthyroidism: realistic goals and focus on evidence.

Peter Laurberg1, Stig Andersen2, Jesper Karmisholt3.   

Abstract

Only a minority of patients with hyperthyroidism caused by Graves' disease will experience cure of disease with a permanent euthyroid state without medication. Antithyroid drugs are useful in attaining euthyroidism, and most patients will gradually enter remission of the autoimmune abnormality after becoming euthyroid. A stable euthyroid state may be sustained by prolonged low-dose medication. The risk of relapse of hyperthyroidism after withdrawal of medication seems to be independent of duration of therapy, once remission has been induced. A number of risk factors influence the outcome of therapy and they should be evaluated when planning duration of therapy with antithyroid drugs.

Entities:  

Keywords:  Graves’ disease; carbimazole; methimazole; propylthiouracil; radioiodine therapy; thyroid surgery

Year:  2006        PMID: 30743772     DOI: 10.1586/17446651.1.1.91

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  1 in total

1.  Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism.

Authors:  Rosario Le Moli; Pasqualino Malandrino; Marco Russo; Fabrizio Lo Giudice; Francesco Frasca; Antonino Belfiore; Riccardo Vigneri
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-11       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.